[1] Bauer AK,Fostel J,Degraff LM, et al. Transcriptomic analysis of pathways regulated by toll-like receptor 4 in a murine model of chronic pulmonary inflammation and carcinogenesis [J]. Mol Cancer, 2009, 8:107.[2] Dehai C, Bo P, Qiang T, et al. Enhanced invasion of lung adenocarcinoma cells after co-culture with THP-1-derived macrophages via the induction of EMT by IL-6 [J]. Immunol Lett, 2014, 160(1):1-10.[3] Malanga D, De Marco C, Guerriero I, et al. The Akt1/IL-6/STAT3 pathway regulates growth of lung tumor initiating cells [J]. Oncotarget, 2015, 6(40):42667-42686.[4] Bromberg J, Wang TC. Inflammation and cancer: IL-6 and STAT3 complete the link [J]. Cancer Cell, 2009, 15(6):79-80.[5] Heinemann V, Stintzing S, Kirchner T, et al. Clinical relevance of EGFR- and KRAS-status in colorectal cancer patients treated with monoclonal antibodies directed against the EGFR [J]. Cancer Treat Rev, 2009, 35(3):262-271.[6] Kazandjian D, Blumenthal GM, Yuan W, et al. FDA approval of gefitinib for the treatment of patients with metastatic EGFR mutation-positive non-small cell lung cancer [J]. Clin Cancer Res, 2016, 22(6):1307-1312.[7] Engels EA. Inflammation in the development of lung cancer: Epidemiological evidence[J]. Expert Rev Anticancer Ther, 2008, 8(4):605-615.[8] Liu Y, Zhang J, Zhou YH, et al. IL-6/STAT3 signaling pathway is activated in plasma cell mastitis [J]. Int J Clin Exp Pathol, 2015.doi:10.1007/s13277-015-4643-0.[9] Jiang Q, Li Q, Chen H, et al. Scutellaria barbata D. Don inhibits growth and induces apoptosis by suppressing IL-6-inducible STAT3 pathway activation in human colorectal cancer cells [J]. Exp Ther Med, 2015, 10(4):1602-1608.[10] Zhao G, Zhu G, Huang Y, et al. IL-6 mediates the signal pathway of JAK-STAT3-VEGF-C promoting growth, invasion and lymphangiogenesis in gastric cancer [J]. Oncol Rep,2016, 35(3):1787-1795.[11] Sahin E, Baycu C, Koparal AT, et al. Resveratrol reduces IL-6 and VEGF secretion from co-cultured A549 lung cancer cells and adipose-derived mesenchymal stem cells [J].Tumor Biol, 2015,32(12):9979-9985.[12] Cavalla F, Osorio C, Paredes R, et al. Matrix metalloproteinases regulate extracellular levels of SDF-1/CXCL12, IL-6 and VEGF in hydrogen peroxide-stimulated human periodontal ligament fibroblasts [J].Cytokine, 2015, 73(1):114-121.[13] Li L, Cheng FW, Wang F, et al. The activation of TLR7 regulates the expression of VEGF, TIMP1, MMP2, IL-6, and IL-15 in Hela cells [J]. Mol Cell Biochem, 2014, 389(1/2):43-49.[14] Weiss TW, Simak R, Kaun C, et al. Oncostatin M and IL-6 induce u-PA and VEGF in prostate cancer cells and correlate in vivo [J]. Anticancer Res, 2011, 31(10):3273-3278.[15] Acquavella N, Clever D, Yu Z, et al. Type Ⅰ cytokines synergize with oncogene inhibition to induce tumor growth arrest [J]. Cancer Immunol Res, 2015, 3(1):37-47.[16] 李 琦.肺功能检查在肺癌的应用[J]. 中国实用内科杂志,2014,34(增1):22-23.[17] 曹 晖,叶雪石,张 瑾.伴血小板增多症的慢性髓系白血病合并肺腺癌1例报告[J].中国实用内科杂志,2014,34(5):522-523. |